Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2)

Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2) were both isolated from the same blood culture of a 5-month-old infant, 8 days after open-heart surgery. He quickly responded to appropriate antibiotics. Carbon substrate assimilation tests and fatty acid analysis clearly differentiated these two rarely pathogenic organisms.

[1]  A. Steigerwalt,et al.  Chryseomonas luteola comb. nov. and Flavimonas oryzihabitans gen. nov., comb. nov., Pseudomonas-like species from human clinical specimens and formerly known, respectively, as groups Ve-1 and Ve-2 , 1987 .

[2]  B. A. Forbes,et al.  Recurrent Pseudomonas luteola (CDC group Ve-1) peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis , 1987, Journal of Clinical Microbiology.

[3]  L. Reimer,et al.  Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis , 1987, Journal of clinical microbiology.

[4]  F. Pien,et al.  Group Ve infection: case report of group Ve-2 septicemia and literature review. , 1986, Diagnostic microbiology and infectious disease.

[5]  K. Komagata,et al.  Two New Species of Pseudomonas: P. oryzihabitans Isolated from Rice Paddy and Clinical Specimens and P. luteola Isolated from Clinical Specimens , 1985 .

[6]  M. Silver,et al.  Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis , 1985, Journal of clinical microbiology.

[7]  H. Alexandre,et al.  An Automatic Micromethod for the Identification of Gram-Negative Bacilli by Carbon Substrate Assimilation Tests , 1985 .

[8]  M. Sorkin.  Unusual Bacterium, GroupVe-2,Causing Peritonitis ina Patient on Continuous Ambulatory Peritoneal Dialysis , 1985 .

[9]  I. Fong,et al.  Prosthetic valve endocarditis caused by group Ve-1 bacteria (Chromobacterium typhiflavum) , 1984, Journal of clinical microbiology.

[10]  Y. Siegman-Igra,et al.  Group VE-1 Septicemia , 1983, Journal of clinical microbiology.

[11]  E. Yourassowsky,et al.  Recherche de glycosidases chez les Pseudomonas du groupe fluorescent: relation entre sérogroupe et activités glycosidasiques chez P. aeruginosa , 1983 .

[12]  C. W. Moss,et al.  Cellular fatty acid composition of strains of three species of Sphingobacterium gen. nov. and Cytophaga johnsonae , 1982 .

[13]  R. Fass,et al.  In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. , 1980, Reviews of infectious diseases.

[14]  F. Gavini,et al.  Carbon Sources Assimilation Tests: Comparison Between a Conventional Method and a Microtechnic (API), in Study of Enterobacteriaceae , 1980 .

[15]  C. W. Moss,et al.  Cellular fatty acid composition of Pseudomonas paucimobilis and groups IIk-2, Ve-1, and Ve-2 , 1979, Journal of clinical microbiology.

[16]  G. Gilardi.  Glucose Nonfermenting Gram-Negative Bacteria in Clinical Microbiology , 1978 .

[17]  F. Pien.  Group VE-2 (Chromobacterium typhiflavum) bacteremia , 1977, Journal of clinical microbiology.

[18]  R. Watson.  Chapter I Substrate Specificities of Aminopeptidases: A Specific Method for Microbial Differentiation , 1976 .

[19]  M. Mandel,et al.  Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology , 1975, Journal of clinical microbiology.

[20]  M. J. Pickett,et al.  Characterization of saccharolytic nonfermentative bacteria associated with man. , 1970, Canadian journal of microbiology.

[21]  M. E. Rhodes.  The cytology of Pseudomonas spp. as revealed by a silver-plating staining method. , 1958, Journal of general microbiology.